• Journal of Environmental Health Sciences
• /
• v.41 no.5
• /
• pp.358-367
• /
• 2015

Objectives: This study was performed to evaluate the analytical method for PAH metabolites in human urine using enzyme hydrolysis and solid-phase extraction coupled with LC-(ESI)-MS/MS technique. Methods: We employed HPLC tandem mass spectrometry techniques with appropriate pre-treatment for analysis of 16 OH-PAHs in human urine. Samples were hydrolysis by ${\beta}$-flucuronidase/Aryl sulfatase, and target compounds were extracted by solid-phase extraction with a strata-x cartridge. Cross-validation was performed between Eulji University and Green Cross laboratories with 200 human urine samples. Results: The accuracies were between 90.3% and 118.8%, and precisions (relative standard deviations) were lower than 10%. The linearity obtained was satisfying for the 16 OH-PAH compounds, with a coefficient of determination ($r^2$) higher than 0.99. The results of cross-validation at the two organizations were compared by ICC (interclass correlation coefficient) values. The cross-validation results were excellent or good for all compounds. Conclusion: An analytical method was validated for low nanogram levels of 16 OH-PAHs in human urine. Also, satisfying results were obtained for method validation such as accuracy, precision and ICC of cross-validation.

• Journal of Acupuncture Research
• /
• v.19 no.1
• /
• pp.1-10
• /
• 2002

Objective : This study was designed to evaluate the possibility of treatment of Diabetes Mellitus by the Acupuncture. Methods : We reviewed 8 patients of Diabetes Mellitus who were diagnosed CVA, low back pain, knee joint pain, etc. They were hospitalized at Sangji University Oriental Medical Hospital during 2001.3.22~2001.10.22. First, we divided into two groups. Group I was administrated by acupuncture at Taep'o(SP21), and was not given any western medicine about Diabetes Mellitus after admission. Group II was administrated by Western medicine. We observed the change of serum glucose(FBS/PP2hrs), urine glucose figure after acupuncture at Taep'o(SP21) for 2 weeks, and compared Group I with Group II. Results : The results obtained as follows ; 1. There was a improvement in Group I(62.5%) and Group II (87.5%). 2. The figure of FBS in Group I was decreased, but there was no signification. There was a significant decrease in Group II (P<0.05). 3. The figure of PP2hrs in Group I was showed a significant decrease(P<0.05). There was also a significant decrease in Group II(P<0.05). 4. The urine glucose of Group I was showed a non-significant increase. There was a significant decrease in Group II(0.05

• YAKHAK HOEJI
• /
• v.36 no.3
• /
• pp.230-240
• /
• 1992

The metabolic profile of doxylamine, N,N-dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy] ethanamine, was determined in the human urine. The free fractions of extracts were obtained without hydrolysis, and the conjugated fractions of extracts were obtained with enzyme hydrolysis using ${\beta}-glucuronidase/arylsulfatase$ from Helix pomatia. The mixture of acetic anhydride/pyridine (10 : 1, v : v) was used to derivatize the urinary extracts and then analyzed by gas chromatography and mass selective detector. N-desmethyldoxylamine, doxylamine carboxylic acid, desaminohydroxydoxylamine, N, N-didesmethyldoxylamine, N-acetyl conjugates of N-desmethyl and N, N-didesmethyldoxylamine, quarternary ammonium N-glucuronide of doxylamine, N-desmethyldoxylamine N-glucuronide and unchanged doxylamine were detected in the human urine obtained after oral treatment with doxylamine succinate. $N-methyl-{\alpha}-hydroxy-2-[1-phenyl-1-(2-pyridinyl)$ ethoxy] ethanamine, which can be a key intermediate of this metabolism, was tentatively identified by the interpretation of its mass spectrum. In this study, we proposed the metabolic pathway of doxylamine in the human on the basis of our data of the identified metabolites of doxylamine.

• Bulletin of the Korean Chemical Society
• /
• v.35 no.4
• /
• pp.1133-1138
• /
• 2014

Ultrahigh performance liquid chromatography-electrospray ionization-tandem mass spectrometry (UPLC-ESI- MS/MS) provides a high-speed method to screen a large number of samples for small molecules with specific properties. In this study, UPLC-ESI-MS/MS with multiple reaction monitoring (MRM) was employed to screen urinary phospholipid (PL) content for biomarkers of prostate cancer. From lists of urinary PLs structurally identified using nanoflow LC-ESI-MS/MS, 52 PL species were selected for quantitative analysis in urine samples between 22 cancer-free urologic patients as controls and 45 prostate cancer patients. Statistical treatment of data by receiver operating characteristic (ROC) analysis yielded 14 PL species that differed significantly in relative concentrations (area under curve (AUC) > 0.8) between the two groups. Among PLs present at higher levels in prostate cancer urine, phosphatidylcholines (PCs) and phosphatidylinositols (PIs) constituted the major head group PLs (3 PCs and 7 PIs). For technical reasons, PL species of low abundance may be underrepresented in data from UPLC-ESI-MS/MS performed in MRM mode. However, the proposed method enables the rapid screening of large numbers of plasma or urine samples in the search for biomarkers of human disease.

• Journal of Veterinary Clinics
• /
• v.17 no.2
• /
• pp.499-501
• /
• 2000

Paraphilmosis, is a condition in which the extruded penis cannot be withdrawn back into the preputial cavity. In this study, the 2 dogs that showed prolonged erection. exposed penis from the sheath and hair surrounding the prepural orifice for several days, were ana1ysis of blood and urine ard carried out surgical treatment. In urinalysis, there were struvites, spermuria and bactera (streptococci) in urine. Firstly, these dogs were treated with non-surgical method, however severe necrosis of the Penis was developed form prolonged exposure and vascular compromise. Finally, partial penile amputation and preputial lengthening were performed and resulted in successful treatment.

• Proceedings of the PSK Conference
• /
• 2003.04a
• /
• pp.284.1-284.1
• /
• 2003

Modified nucleosides and polyamines excreted in urine are well-known as biochemical markers for cancer. The metabolomics on the urinary nucleosides and polyamines is thus gaining interest in the cancer study. In this study, the levels of nucleosides and polyamines in urine samples from cancer patients under acupuncture treatment were determined by high resolution capillary electrophoresis and gas chromatography, respectively. (omitted)

• Progress in Medical Physics
• /
• v.33 no.4
• /
• pp.101-107
• /
• 2022

Purpose: Radiotherapy after bladder filling protocol (BFP) is known to enhance treatment quality and reduce side effects in prostate cancer, a common male solid cancer globally. However, due to the need to hold back urine during treatment, patients frequently complain of discomfort, and treatment is frequently suspended when patients urinate during treatment and urine penetrates the treatment device, causing malfunction. Therefore, the effect of minimizing treatment time when partial-arc volumetric modulated arc therapy (VMAT) was used instead of full-arc was assessed in this study. Methods: A total of 70 plans were created in 10 patients using 7 different arc sizes, and the treatment time for each plan was calculated. Results: Reduced arc size by half resulted in a 54.4% decrease in mean treatment duration, with a proportional tendency observed. Furthermore, the effect of VMAT arc size reduction on target dose homogeneity was significantly limited, and the effect on surrounding organs at risk (OAR) was negligible. It should be noted, however, that when the arc size decreases by >40%, the dose increases in the area without OAR around the target. Conclusions: The results of this study demonstrated that partial-arc VMAT for enhancing treatment convenience and efficacy of prostate cancer patients undergoing BFP can achieve a considerable reduction in treatment time while preserving treatment quality, and it is expected to be useful for partial-arc VMAT plan design and implementation in practice.

• CELLMED
• /
• v.10 no.2
• /
• pp.17.1-17.5
• /
• 2020

Background: Chronic kidney disease (CKD) is affective a large portion of the world population prompting the need for extensive healthcare resources such as lifelong dialysis or kidney transplantation. The beneficial effect of conventional therapy in controlling the CKD progression remains a challenge due to their relative efficacy, safety, and accessibility. On the other hand, Unani medicine provides a therapeutic regimen that consists of a combination of treatment from rehabilitation to herbal pharmacotherapy. Methods: Two cases of chronic kidney disease were treated with dietotherapy, regimenal therapy ('bukhoor aam') and oral herbal drugs for 2-3 weeks. Endpoints of evaluation were symptoms and signs of the CKD, kidney function test, urine albumin, urine RBC, hemoglobin and liver function test. Result: Notable improvement was observed in the endpoints. Conclusion: Unani treatment was observed preliminarily beneficial in the treatment of chronic kidney disease. Rigorous pharmacological and clinical studies should be performed to warrant their efficacy and safety in CKD individuals.

• Journal of the Korean Chemical Society
• /
• v.47 no.1
• /
• pp.13-18
• /
• 2003

The effect of ultrasonic decomposition was introduced to develop a pretreatment method for the analysis of potassium ion in human urine by potentiometry. N-(4’-benzo-15-crown-5)-anthracene-9-imine, which has a good selectivity coefficient for potassium against ammonium, was used as an ion-selective material for the determination of potassium in urine with relatively high concentration of $NH_4{^+}$. Protenis in urine be removed by 85.1% when the sample acidified with 1.0 M $HNO_3$ was preteated for 100 s by sonication. Potential response of the membrane electrode in the pretreated urine had a slope of 54.6(${\pm}0.2,\;n=5$) mV/decade over the linear range of log $[K^+]$=-5~-1(r=0.9997). When an oxidant, $H_2O_2$, was addwd to the urine sonicated with $HNO_3$, the deproteinization increased 10% more than that in case if only $HNO_3$ and then the maximum ratio of ca. 95% was obtained. Moreover, the Nernstian slope for $K^+$ added to the urinary sample increased to 56.7(${\pm}0.1,\;n=3$) mV/decade. When the calibration curves were measured, the slopes did not vary even after the electrode was successively used 20 times with ultrasonic cleaning. The results showed that an ultrasonic pretreatment method provides simplicity in use, reduced treatment time and improved potentiometric characteristics of the membrane as the method effectively removes ca. 95% of proteins in urine.

• The Journal of Korean Medicine
• /
• v.23 no.1
• /
• pp.156-169
• /
• 2002

Objectives : This experimental study was performed to prove the effect of Ikryung-Tang (yiling-tang; IRT) and Ikryung-tangkamibang (yiling-tangjiaweifang; IRT I, IRT II) on rats with nephrosis induced by a single intravenous injection of puromycin aminonucleoside (PAN). Methods : The effects of IRT, IRT I and IRT II on PAN nephrosis were evaluated by measuring the gene expression of IL-4, $IFN-{\gamma}$ and the concentrations of IgE, albumin, total protein, cholesterol, triglyceride, creatinine, and BUN in the serum and the volume & amount of protein of the 24hrs' urine. Results : In the gene expression linked T cell specialization, IRT II inhibited IL-4 and IgE but IRT and IRT I showed no significant difference compared with control group. On the other hand, IRT, IRT I and IRT II increased $IFN-{\gamma}$ compared with the control group. In the urine protein, serum albumin, total protein, BUN, and creatinine, IRT I especially showed more. significant effect than other groups. In the serum cholesterol and triglyceride, IRT II especially showed more significant effect than other groups. In the urine volume during 24 hrs, IRT especially showed more significant effect than other groups. Conclusions : According to the above results, it is suggested that IRT is effective for the treatment of edema, IRT I is effective for the treatment of hypoproteinemia and kidney dysfunction, IRT II is effective for immune modulation and the treatment of cholesteremia. Therefore IRT, IRT I and IRT II seem to be available for treating nephrosis in clinical practice.